RX-37
CAS No. 1627715-60-9
RX-37 ( RX 37;RX37;BET bromodomain inhibitor RX-37 )
Catalog No. M12417 CAS No. 1627715-60-9
A potent and specific BET bromodomain inhibitor with Ki of 3.2-24.7 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 1323 | Get Quote |
|
50MG | 2682 | Get Quote |
|
100MG | 3600 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRX-37
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and specific BET bromodomain inhibitor with Ki of 3.2-24.7 nM.
-
DescriptionA potent and specific BET bromodomain inhibitor with Ki of 3.2-24.7 nM for BD1 and BD2 domains of BRD2, BRD3, and BRD4; shows an excellent selectivity over other non-BET bromodomain-containing proteins with the exception of CREBBP (Kd=670 nM); potently and selectively inhibits cell growth in human acute leukemia cell lines harboring the rearranged MLL1 gene (IC50=20 nM for MV4;11 cells).
-
SynonymsRX 37;RX37;BET bromodomain inhibitor RX-37
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1627715-60-9
-
Formula Weight413.48
-
Molecular FormulaC24H23N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=C(C2=C(C)ON=C2C)C=C(NC3=C4C(C5=C(C)NN=C5C6CC6)=NC=C3)C4=C1
-
Chemical Name4-(1-(3-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-8-methoxy-5H-pyrido[4,3-b]indol-7-yl)-3,5-dimethylisoxazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ran X, et al. J Med Chem. 2015 Jun 25;58(12):4927-39.
molnova catalog
related products
-
NI-42
A potent, selective and orally active BRPF1 bromodomain inhibitor with IC50 of 7.9 nM.
-
BAZ2-ICR
BAZ2-ICR is a potent, selective and cell-active inhibitor of BAZ2A and BAZ2B bromodomains.
-
CD 161
A potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively.